.mtpc: Difference between revisions
No edit summary |
m Text replacement - "Category:TLD" to "Category:GTLD" Tags: Mobile edit Mobile web edit |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{TLD| | {{TLD| | ||
|logo = | |logo = | ||
|status = | |status = Terminated | ||
|country = | |country = | ||
|language = | |language = | ||
|translation = | |translation = | ||
|manager = | |manager = | ||
|registryprovider = | |registryprovider = | ||
|registrations = | |registrations = | ||
|date = | |date = | ||
| Line 12: | Line 12: | ||
|category = | |category = | ||
|community = | |community = | ||
|priority = | |priority = | ||
|keypeople = | |keypeople = | ||
}} | }} | ||
'''.mtpc''' | '''.mtpc''' was a [[Brand TLD]] delegated to the [[Root Zone|DNS Root Zone]] in [[ICANN]]'s [[New gTLD Program]]. The [[Mitsubishi Tanabe Pharma Corporation]] (MTPC) was successful in it's application and managed the TLDs [[Registry]].<ref name="delegation">[http://newgtlds.icann.org/en/program-status/delegated-strings Delegated String, ICANN.org] Retrieved 04 Mar 2015</ref> In a letter dated 15 November 2016, MTPC notified ICANN of its intent to terminate the [[Registry Agreement]] as of 14 May 2017. <ref>[https://www.icann.org/sites/default/files/tlds/mtpc/mtpc-termination-notice-16nov16-en.pdf .mtpc Termination Notice]</ref> | ||
==Application Details== | ==Application Details== | ||
| Line 31: | Line 31: | ||
{{reflist}} | {{reflist}} | ||
[[Category: | [[Category:GTLD]] | ||
Latest revision as of 18:27, 28 November 2024
| Status: | Terminated |
| Type: | Brand TLD |
More information: 
| |
.mtpc was a Brand TLD delegated to the DNS Root Zone in ICANN's New gTLD Program. The Mitsubishi Tanabe Pharma Corporation (MTPC) was successful in it's application and managed the TLDs Registry.[1] In a letter dated 15 November 2016, MTPC notified ICANN of its intent to terminate the Registry Agreement as of 14 May 2017. [2]
Application Details
The following is excerpted from the applicant's response to question #18:
"Mitsubishi Tanabe Pharma Corporation is a global research-driven pharmaceutical company, which engages in research and development, as well as manufacturing and sales, of pharmaceutical product. The company was established in October 2007 through the merger of Tanabe Seiyaku Co., Ltd., founded in 1678, and Mitsubishi Pharma Corporation. Sine that time, the company has contributed to the health of people through the provision of distinctive pharmaceuticals, including drugs for inflammatory and autoimmune diseases, cerebral diseases, and metabolic and cardiorascular diseases as well as psychiatric and neurological drugs, narcotics, plasma fractionation products, and vaccines. Based on its philosophy ʺWe contribute to the healthier lives of people around the world through the creation of pharmaceuticalsʺ, Mitsubishi Tanabe Pharma strives to be a company that is trusted by communities.
.mtpc, which stands for Mitsubishi Tanabe Pharma Corporation, is a domain for Mitsubishi Tanabe Pharma and its stakeholders. The primary purpose of .mtpc is to consolidate Mitsubishi Tanabe Pharma-related domain names registered under various TLDs into an official .mtpc extension
..
n addition, .mtpc is different from other existing TLDs because it will be only available to Mitsubishi Tanabe Pharma Corporation and its stakeholders. With its restrictive rules and comprehensive abuse handling processes, Mitsubishi Tanabe Pharma Corporation expects minimal abusive domain name registrations in the .mtpc name space. This means that information provided by .mtpc will be reliable and Internet users will be able to enjoy the name space with confidence. .mtpc will deliver unprecedented trust to Internet users, which Mitsubishi Tanabe Pharma Corporation believes will spur further positive competition and innovation in the industry."[3]
References
- ↑ Delegated String, ICANN.org Retrieved 04 Mar 2015
- ↑ .mtpc Termination Notice
- ↑ Application Download, gTLDresult.ICANN.org Retrieved 18 Feb 2013